Lipoprotein(a) Test

What is Lipoprotein(a)?

Lipoprotein(a) — usually written Lp(a) — is a particle in the blood that carries cholesterol, similar in structure to LDL ("bad") cholesterol but with an extra protein, apolipoprotein(a), attached to it. That extra protein makes Lp(a) "stickier" than ordinary LDL, which is part of why it is linked to plaque buildup in the arteries.

What makes Lp(a) different from almost every other cholesterol marker is how fixed it is: your Lp(a) level is more than 90% genetically determined, set early in life by variants in the LPA gene, and it changes very little over your lifetime. Diet and exercise, which move LDL and triglycerides substantially, barely budge Lp(a). That stability is exactly why clinicians treat it as a once-in-a-lifetime measurement rather than something to track every year.

Lipoprotein(a) Normal Range

There is no single universal cutoff: guidelines differ slightly, and individual laboratories use different assays. But the commonly used bands are consistent enough to be useful:

Two cautions before comparing your number to any table. First, Lp(a) is reported in one of two units — mass (mg/dL) or particle number (nmol/L) — and the two are not interchangeable, because the Lp(a) protein varies in size from person to person and there is no reliable conversion. Always read your result in the units your lab actually used. Second, risk rises along a continuum: observational data suggest cardiovascular risk may roughly double at levels above about 250 nmol/L (~100 mg/dL), so a number just under a cutoff is not a clean bill of health, and a high number matters more if you also have high LDL, diabetes, high blood pressure, or a positive calcium score.²

Why High Lp(a) Is a Heart Risk

Lp(a) is considered a causal risk factor for cardiovascular disease, not merely a marker of it: genetic studies show that people born with lifelong high Lp(a) develop more artery disease, independent of their other risk factors. The particle promotes all three steps of artery disease — it accelerates plaque buildup, carries an inflammatory signal, and makes clots more likely. Beyond heart attack and stroke, high Lp(a) is also a causal risk factor for calcific aortic valve stenosis, a narrowing of the heart's aortic valve.³

Elevated Lp(a) is common: roughly one in five adults has a level in the elevated range. It also runs in families — because the trait is inherited in a near-co-dominant pattern, about half of the first-degree relatives of someone with markedly elevated Lp(a) will have elevated levels too, which is why guidelines recommend checking family members of people with a high result.¹

Lp(a) vs LDL Cholesterol

Lp(a) and LDL cholesterol are often confused because they look alike and travel in the same laboratory space. They differ in the ways that matter:

Because standard LDL measurements can include some of the cholesterol carried by Lp(a), a person with very high Lp(a) may have an LDL number that looks worse than their true LDL. Clinicians sometimes adjust the LDL estimate when Lp(a) is very high. See also ApoB test, which counts the total number of artery-clogging particles — the two tests answer different questions and are often ordered together.

Who Should Get Tested

The 2026 ACC/AHA dyslipidemia guideline recommends measuring Lp(a) at least once in every adult, as part of cardiovascular risk assessment.¹ Before that recommendation, testing was aimed at higher-suspicion groups — and those groups still deserve it most urgently:

• Family history of early heart disease — a parent or sibling with a heart attack, stent, or bypass before about 55 (men) or 65 (women).
• Personal early cardiovascular disease — a heart attack, stroke, or stents at a young age, especially with a normal-looking lipid panel.
• Familial hypercholesterolemia — the inherited high-cholesterol condition, where Lp(a) adds further risk information.
• Recurrent events despite treatment — another heart attack or stent while already on a statin with controlled LDL.
• Calcific aortic valve disease — narrowing of the aortic valve, which Lp(a) helps cause.
• A first-degree relative with elevated Lp(a) — cascade screening of family members is recommended, since about half will share the trait.¹

Because levels barely change over a lifetime, repeat testing is usually unnecessary — though clinicians may recheck values that land near a decision threshold, since assays can vary.

What Does a High Lp(a) Result Mean?

A high Lp(a) result identifies an inherited, lifelong cardiovascular risk factor — it is information, not a diagnosis. A level of ~50 mg/dL (~125 nmol/L) or above is treated as a risk-enhancing factor that strengthens the case for more aggressive control of everything that can be changed: LDL cholesterol, blood pressure, blood sugar, smoking, and overall risk-factor treatment. It is not an emergency, and it does not mean a heart attack is imminent.

What changes after a high result is the intensity of prevention. Your clinician may aim for a lower LDL target, consider earlier or more intensive therapy, and look harder at imaging (such as a coronary calcium scan) to see whether plaque has already accumulated. Discuss with your clinician whether family members should be tested too — that single follow-up conversation is one of the most valuable things a high result can trigger.

Can You Lower Lp(a)?

The honest answer first: nothing in daily life lowers Lp(a) meaningfully. Diet, exercise, and weight loss — which improve nearly every other risk marker — have minimal effect on Lp(a), and statins, the workhorse cholesterol drugs, do not reduce it either (some studies even suggest a small rise). This is why the guideline emphasis is on finding the number early and then managing everything else around it.

What does move Lp(a)? PCSK9 inhibitor medicines lower it modestly, by roughly a quarter to a third — but they are prescribed for LDL lowering under specific clinical criteria, not as Lp(a) drugs, and whether to use one is a clinician's decision. A newer generation of medicines designed specifically to lower Lp(a) — such as pelacarsen, olpasiran, and zerlasiran — is in late-stage clinical trials; none is yet part of routine care. If you see claims about supplements or home remedies that "lower Lp(a)", treat them with skepticism and discuss any plan with your clinician before acting on it.

How Is the Test Done?

Lp(a) is measured from a standard blood draw. Fasting is usually not required, but follow the instructions from the ordering lab. Importantly, Lp(a) is not part of a standard lipid panel — it has to be ordered separately, which is one reason testing remains below 1% of the general population even as guidelines now recommend it for all adults. Some labs report in mg/dL and others in nmol/L; if you are comparing results, make sure the units match.

Lipoprotein(a) test price in India

In India, an Lp(a) test typically costs roughly ₹1,200–₹3,000, though the price varies by city and laboratory. NABL-accredited labs in most metros offer home sample collection, sometimes with an added phlebotomy charge, so confirm the all-in price before the sample is drawn.

In the United States, the test is typically in the region of $50–$150 when paid out of pocket at large reference labs, with the actual amount varying by lab and insurance coverage. Because Lp(a) is ordered separately from the lipid panel, it is sometimes billed as an add-on test — always confirm the price with the ordering lab before testing.

Frequently Asked Questions

Pharmacist’s practical notes

Timing is the first thing to get right: because Lp(a) is genetically fixed, the test is ideally drawn once in adulthood — the 2026 ACC/AHA guideline made it a Class I recommendation for all adults, but in practice the highest value is in people with a family history of early heart disease, where one test can redirect an entire family's prevention plan. If your doctor has never mentioned it, bringing it up at your next lipid check is reasonable; it is a single extra tube of blood, not a separate visit.

Read the units before you read the number. A result of "48" in mg/dL is near the elevated cutoff, while "48" in nmol/L is comfortably low — mixing up the units is the most common way patients misread this test, and there is no reliable conversion between the two. When you bring the report to your clinician, bring the lab's reference range with it, because cutoffs differ between guidelines and assays.

Medication review matters in the other direction: statins do not lower Lp(a), so a person can have a perfect-looking LDL on a statin while Lp(a) quietly adds risk — that residual risk is exactly what the test is for. PCSK9 inhibitors lower Lp(a) modestly (roughly a quarter to a third), but they are prescribed under specific clinical criteria, not as Lp(a) therapy; the targeted Lp(a)-lowering medicines in trials are not yet routine care. Do not start, stop, or change any medicine because of an Lp(a) result — discuss intensification of overall risk-factor control with your clinician instead.

Finally, the family conversation. Because elevated Lp(a) is inherited in a near-co-dominant pattern, a markedly high result means roughly half of your first-degree relatives likely share it — cascade screening of parents, siblings, and adult children is guideline-recommended and is the single highest-yield action after a high result. It is a simple, once-in-a-lifetime blood test for them too, and many labs offer it as an add-on to a routine lipid panel, so confirm the combined price before the draw.

References

1. 2026 ACC/AHA dyslipidemia guideline: once-in-lifetime Lp(a) screening for all adults (Class I recommendation). Healio summary.
2. American College of Cardiology. An Update on Lipoprotein(a): Testing, Treatment, and Guideline Recommendations.
3. Lipoprotein(a) in the statin era: from risk marker to therapeutic target. Frontiers in Pharmacology. 2026.